N. Vogelzang Et Al. , "Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma," JOURNAL OF CLINICAL ONCOLOGY , vol.21, no.14, pp.2636-2644, 2003
Vogelzang, N. Et Al. 2003. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. JOURNAL OF CLINICAL ONCOLOGY , vol.21, no.14 , 2636-2644.
Vogelzang, N., Rusthoven, J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., ... Gatzemeier, U.(2003). Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. JOURNAL OF CLINICAL ONCOLOGY , vol.21, no.14, 2636-2644.
Vogelzang, NJ Et Al. "Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma," JOURNAL OF CLINICAL ONCOLOGY , vol.21, no.14, 2636-2644, 2003
Vogelzang, NJ Et Al. "Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma." JOURNAL OF CLINICAL ONCOLOGY , vol.21, no.14, pp.2636-2644, 2003
Vogelzang, N. Et Al. (2003) . "Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma." JOURNAL OF CLINICAL ONCOLOGY , vol.21, no.14, pp.2636-2644.
@article{article, author={NJ Vogelzang Et Al. }, title={Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2003, pages={2636-2644} }